Tyler Oe
Overview
Explore the profile of Tyler Oe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
202
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eubank M, Svihra Jr J, DiBona K, Sommers M, Oe T, Strnadel J, et al.
Front Oncol
. 2023 Jan;
12:1063781.
PMID: 36686794
Purpose: To develop a safe and precise method for intraprostatic injection, and to establish correlation between the volume of ethanol injectate and the volume of subsequent infiltrated prostate tissue. Materials...
2.
Abdelkhalek A, Clarke P, Sommers M, Oe T, Andersen T, Andersen C, et al.
Scand J Urol
. 2021 Aug;
55(6):498-504.
PMID: 34369841
Aims: experiments were performed to establish and validate a rat model of urethral sphincter injury and to develop a method for leak point pressure (LPP) measurements performed repeatedly in the...
3.
Cotzomi E, Stathopoulos P, Lee C, Ritchie A, Soltys J, Delmotte F, et al.
Brain
. 2019 May;
142(6):1598-1615.
PMID: 31056665
Neuromyelitis optica spectrum disorders (NMOSD) constitute rare autoimmune disorders of the CNS that are primarily characterized by severe inflammation of the spinal cord and optic nerve. Approximately 75% of NMOSD...
4.
Schickel J, Kuhny M, Baldo A, Bannock J, Massad C, Wang H, et al.
Sci Immunol
. 2016 Dec;
1(1).
PMID: 27917411
The () allele is one of the main risk factors associated with many autoimmune diseases and correlates with a defective removal of developing autoreactive B cells in humans. To determine...
5.
Chamberlain N, Massad C, Oe T, Cantaert T, Herold K, Meffre E
J Clin Invest
. 2015 Dec;
126(1):282-7.
PMID: 26642366
Type 1 diabetes (T1D) patients show abnormalities in early B cell tolerance checkpoints, resulting in the accumulation of large numbers of autoreactive B cells in their blood. Treatment with rituximab,...
6.
Cantaert T, Schickel J, Bannock J, Ng Y, Massad C, Oe T, et al.
Immunity
. 2015 Nov;
43(5):884-95.
PMID: 26546282
Activation-induced cytidine deaminase (AID), the enzyme-mediating class-switch recombination (CSR) and somatic hypermutation (SHM) of immunoglobulin genes, is essential for the removal of developing autoreactive B cells. How AID mediates central...
7.
Romberg N, Virdee M, Chamberlain N, Oe T, Schickel J, Perkins T, et al.
J Allergy Clin Immunol
. 2015 Jun;
136(5):1315-25.
PMID: 26100089
Background: Heterozygous C104R or A181E TNF receptor superfamily member 13b (TNFRSF13B) mutations impair removal of autoreactive B cells, weaken B-cell activation, and convey to patients with common variable immune deficiency...